Skip to main content
Clinical Trials/NCT04323839
NCT04323839
Completed
Not Applicable

PRIORITY (Pregnancy Coronavirus Outcomes Registry)

University of California, San Francisco1 site in 1 country1,333 target enrollmentMarch 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
University of California, San Francisco
Enrollment
1333
Locations
1
Primary Endpoint
Clinical presentation
Status
Completed
Last Updated
last year

Overview

Brief Summary

PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.

Detailed Description

The investigators will recruit women age 13 or older under investigation for COVID-19 or with confirmed COVID-19 at any clinical state across the United States. Eligible participants will be identified through voluntary physician referrals. When an eligible patient is referred to the PRIORITY Coordinating Center at UCSF, a UCSF study coordinator will follow-up by phone with the patient and consent verbally. The participant will be asked to complete an approval to release medical information. The investigators will use patient questionnaires to assess symptoms, maternal clinical course, pregnancy outcomes, and neonatal outcomes from initial investigation of COVID-19 to 12 months. The investigators will also obtain all medical records for the participant to data abstract key clinical and pregnancy outcomes.

Registry
clinicaltrials.gov
Start Date
March 20, 2020
End Date
April 26, 2022
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pregnant women or women who have been pregnant within the last 6 weeks
  • Able to give informed consent
  • Diagnosed with COVID-19; or being evaluated for COVID-19 ("patient under investigation") since January 1, 2020

Exclusion Criteria

  • \<13 years of age.

Outcomes

Primary Outcomes

Clinical presentation

Time Frame: Baseline to 12 months

presenting symptoms and testing

Disease prognosis outcomes

Time Frame: Baseline to 12 months

Clinical outcomes with resolution of illness

Neonatal outcomes

Time Frame: Baseline to 12 months

Neonatal outcomes among infants born to women with COVID-19

Obstetric outcomes

Time Frame: Baseline to 12 months

Obstetric outcomes among women infected with COVID-19

Pregnancy outcomes

Time Frame: Baseline to 12 months

Pregnancy outcomes among women infected with COVID-19

Modes of transmission of COVID-19

Time Frame: Baseline to 12 months

Transmission of COVID-19 from mother to infant

Study Sites (1)

Loading locations...

Similar Trials